These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31317318)

  • 1. Expression of Breast Cancer-Related Epitopes Targeting the IGF-1 Receptor in Chimeric Human Parvovirus B19 Virus-Like Particles.
    Salazar-González JA; Ruiz-Cruz AA; Bustos-Jaimes I; Moreno-Fierros L
    Mol Biotechnol; 2019 Oct; 61(10):742-753. PubMed ID: 31317318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer.
    Jiménez-Chávez ÁJ; Nava-García BK; Bustos-Jaimes I; Moreno-Fierros L
    Immunol Lett; 2021 Nov; 239():77-87. PubMed ID: 34508790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with multi-epitope virus-like particles of B19 parvovirus reduce tumor growth and lung metastasis in an aggressive breast cancer mouse model.
    Jiménez-Chávez ÁJ; Moreno-Fierros L; Bustos-Jaimes I
    Vaccine; 2019 Nov; 37(49):7256-7268. PubMed ID: 31570181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
    Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
    Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
    Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C
    Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus.
    Amexis G; Young NS
    J Infect Dis; 2006 Sep; 194(6):790-4. PubMed ID: 16941345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
    Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
    Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
    Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
    Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
    Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
    Pan Q; He K; Wang Y; Wang X; Ouyang W
    Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
    Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
    Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
    J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a parvovirus B19 vaccine candidate.
    Chandramouli S; Medina-Selby A; Coit D; Schaefer M; Spencer T; Brito LA; Zhang P; Otten G; Mandl CW; Mason PW; Dormitzer PR; Settembre EC
    Vaccine; 2013 Aug; 31(37):3872-8. PubMed ID: 23827313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.